Literature DB >> 31010806

Genome-Wide CRISPR Screen Reveals Autophagy Disruption as the Convergence Mechanism That Regulates the NRF2 Transcription Factor.

Michael J Kerins1, Pengfei Liu1, Wang Tian1, William Mannheim1, Donna D Zhang2,3, Aikseng Ooi2,3.   

Abstract

The nuclear factor (erythroid 2)-like 2 (NRF2 or NFE2L2) transcription factor regulates the expression of many genes that are critical in maintaining cellular homeostasis. Its deregulation has been implicated in many diseases, including cancer and metabolic and neurodegenerative diseases. While several mechanisms by which NRF2 can be activated have gradually been identified over time, a more complete regulatory network of NRF2 is still lacking. Here we show through a genome-wide clustered regularly interspaced short palindromic repeat (CRISPR) screen that a total of 273 genes, when knocked out, will lead to sustained NRF2 activation. Pathway analysis revealed a significant overrepresentation of genes (18 of the 273 genes) involved in autophagy. Molecular validation of a subset of the enriched genes identified 8 high-confidence genes that negatively regulate NRF2 activity irrespective of cell type: ATG12, ATG7, GOSR1, IFT172, NRXN2, RAB6A, VPS37A, and the well-known negative regulator of NRF2, KEAP1 Of these, ATG12, ATG7, KEAP1, and VPS37A are known to be involved in autophagic processes. Our results present a comprehensive list of NRF2 negative regulators and reveal an intimate link between autophagy and NRF2 regulation.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  CRISPR; KEAP1; NFE2L2; NRF2; autophagy; gene reporters; genomics; molecular biology; oxidative stress; signal transduction

Mesh:

Substances:

Year:  2019        PMID: 31010806      PMCID: PMC6580702          DOI: 10.1128/MCB.00037-19

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  120 in total

1.  Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.

Authors:  Donna D Zhang; Mark Hannink
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 2.  Transcriptional interference--a crash course.

Authors:  Keith E Shearwin; Benjamin P Callen; J Barry Egan
Journal:  Trends Genet       Date:  2005-06       Impact factor: 11.639

3.  Targeted Deletion of Autophagy Genes Atg5 or Atg7 in the Chondrocytes Promotes Caspase-Dependent Cell Death and Leads to Mild Growth Retardation.

Authors:  Karuna K Vuppalapati; Thibault Bouderlique; Phillip T Newton; Vitaliy O Kaminskyy; Henrik Wehtje; Claes Ohlsson; Boris Zhivotovsky; Andrei S Chagin
Journal:  J Bone Miner Res       Date:  2015-08-07       Impact factor: 6.741

4.  Analysis the prognostic values of solute carrier (SLC) family 39 genes in gastric cancer.

Authors:  Bisha Ding; Weiyang Lou; Liang Xu; Ruohan Li; Weimin Fan
Journal:  Am J Transl Res       Date:  2019-01-15       Impact factor: 4.060

5.  Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma.

Authors:  Ling-Jie Bao; Melba C Jaramillo; Zhen-Bo Zhang; Yun-Xi Zheng; Ming Yao; Donna D Zhang; Xiao-Fang Yi
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

6.  Aberrant Keap1 methylation in breast cancer and association with clinicopathological features.

Authors:  Raffaela Barbano; Lucia Anna Muscarella; Barbara Pasculli; Vanna Maria Valori; Andrea Fontana; Michelina Coco; Annamaria la Torre; Teresa Balsamo; Maria Luana Poeta; Giovanni Francesco Marangi; Evaristo Maiello; Marina Castelvetere; Fabio Pellegrini; Roberto Murgo; Vito Michele Fazio; Paola Parrella
Journal:  Epigenetics       Date:  2012-12-18       Impact factor: 4.528

Review 7.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

8.  Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis.

Authors:  Tongde Wu; Fei Zhao; Beixue Gao; Can Tan; Naoko Yagishita; Toshihiro Nakajima; Pak K Wong; Eli Chapman; Deyu Fang; Donna D Zhang
Journal:  Genes Dev       Date:  2014-03-17       Impact factor: 11.361

9.  MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma.

Authors:  Yongbo Yu; Jie Zhang; Yaqiong Jin; Yeran Yang; Jin Shi; Feng Chen; Shujing Han; Ping Chu; Jie Lu; Huanmin Wang; Yongli Guo; Xin Ni
Journal:  Cancer Cell Int       Date:  2018-01-04       Impact factor: 5.722

Review 10.  The role of Nrf2 signaling in counteracting neurodegenerative diseases.

Authors:  Albena T Dinkova-Kostova; Rumen V Kostov; Aleksey G Kazantsev
Journal:  FEBS J       Date:  2018-01-29       Impact factor: 5.542

View more
  5 in total

1.  Differential and overlapping targets of the transcriptional regulators NRF1, NRF2, and NRF3 in human cells.

Authors:  Pengfei Liu; Michael J Kerins; Wang Tian; Durga Neupane; Donna D Zhang; Aikseng Ooi
Journal:  J Biol Chem       Date:  2019-10-18       Impact factor: 5.157

Review 2.  Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.

Authors:  Aikseng Ooi
Journal:  Semin Cancer Biol       Date:  2019-11-02       Impact factor: 15.707

3.  Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.

Authors:  Katarína Smolková; Edit Mikó; Tünde Kovács; Alberto Leguina-Ruzzi; Adrienn Sipos; Péter Bai
Journal:  Antioxid Redox Signal       Date:  2020-03-18       Impact factor: 8.401

4.  NRXN2 Possesses a Tumor Suppressor Potential via Inhibiting the Growth of Thyroid Cancer Cells.

Authors:  Cui Ma; Youyou Zhang
Journal:  Comput Math Methods Med       Date:  2021-11-03       Impact factor: 2.238

5.  Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations.

Authors:  Christina G Towers; Darya Wodetzki; Andrew Thorburn
Journal:  J Cell Biol       Date:  2020-01-06       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.